{"version":"1.0","type":"link","title":"Prediction of neoadjuvant therapy response to HER2-positive and triple-negative breast cancer: a multicenter proof-of-concept study.","author_name":"Fu M 외","author_url":"https://prs-insight.online/author/Fu%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/92014","thumbnail_width":1200,"thumbnail_height":630}